Dexamethasone reduces emesis after major gastrointestinal surgery trial (DREAMS)

DREAMS (Dexamethasone Reduces Emesis After Major Gastrointestinal Surgery) is a double-blind, phase IV, multi-centre randomised controlled trial designed to determine if apre-operative dexamethasone reduces post-operative nausea and vomiting in patients undergoing elective colorectal resections.

The DREAMS study is the first trial of an investigational medicinal product (CTIMP) to be developed by the West Midlands Research Collaborative.

 DREAMS is currently recruiting at 38 UK sites and and has recruited over 800 patients, the trial has been funded by a grant from the Bowel Disease Research Foundation, and we have now been awarded funding from the Research for Patient Benefit Programme (RfPB).